Outlook Therapeutics Stock Forecast

Buy or Hold candidate since May 20, 2026 Gain 184.51%

The Outlook Therapeutics Inc. stock price fell by -2.28% on the last day (Friday, 5th Jun 2026) from $0.795 to $0.777. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 15.72% from a day low at $0.732 to a day high of $0.85. The price has fallen in 6 of the last 10 days but is still up by 133.24% over the past 2 weeks. Volume has increased on the last day by 870 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 12 million shares were bought and sold for approximately $9.28 million.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $0.86 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 37.88% during the next 3 months and, with a 90% probability hold a price between $0.377 and $1.18 at the end of this 3-month period.

OTLK Signals & Forecast

There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Monday, June 01, 2026, and so far it has fallen -7.86%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The Outlook Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.787. On a fall, the stock will find some support from the long-term average at approximately $0.384. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Outlook Therapeutics Inc. stock

Outlook Therapeutics Inc. finds support from accumulated volume at $0.740 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.115 between high and low, or 15.72%. For the last week, the stock has had daily average volatility of 17.12%.

The Outlook Therapeutics Inc. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $0.744 (-4.26%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 87 and this increases the risk substantially. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (OTLK) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Outlook Therapeutics Inc. to open at $0.786, and during the day (based on 14 day Average True Range), to move between $0.732 and $0.82, which gives a possible trading interval of +/-$0.0898 (+/-12.28%) up or down from last closing price. If Outlook Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 12.28% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.795 (2.33%) than the support at $0.740 (4.73%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Outlook Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Outlook Therapeutics Inc. stock to perform well in the short-term.

Current score: 3.056 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $0.786 ( 1.14%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk